Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking Cessation 1Motor Activity 1Lung Neoplasms 1Inflammation 1

Interventions

Aspirin 2sulforaphane 1polyphenon E 1cytisine 1Varenicline 1Tomography, X-Ray Computed 1Tomography 1Tobacco Use Cessation Devices 1Tea 1Spirometry 1Secondary Prevention 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Nicotine Chewing Gum 1Hematologic Tests 1Fluorodeoxyglucose F18 1Exercise 1Diet Therapy 1Diagnostic Imaging 1Bupropion 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Smoking Cessation × Spirometry × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡